G. Guy
Medical Hypotheses · with Russo · 2006
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Who trusts G. Guy
- V. Di Marzo (in Pharmacology)
Papers from G. Guy's perspective
Ordered by how strongly the researchers G. Guy trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide (British Journal of Pharmacology)
- Agonistic Properties of Cannabidiol at 5-HT1a Receptors (Neurochemical Research)
- Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. (The Lancet)
- The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. (Proceedings of the National Academy of Sciences of the United States of America)
- The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) (British Journal of Pharmacology)
- Leptin-regulated endocannabinoids are involved in maintaining food intake (Nature)
- Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. (Brain Research)
- Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1 (Nature)
- Variance component model to account for sample structure in genome-wide association studies (Nature Genetics)
- Gene Ontology: tool for the unification of biology